title: Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.
abstract: HMGB1 (high-mobility group box 1) protein, a pleiotropic cytokine released by several cell types under physiological and pathological conditions, has been identified as a signal molecule active on A431 cells. Although extracellular HMGB1 itself does not trigger any detectable signalling effect on these cells, it induces an increased susceptibility to EGF (epidermal growth factor) stimulation. Specifically, at concentrations of EGF which promote undetectable or limited cell responses, the addition of sub-nanomolar concentrations of HMGB1 potentiates the effect of EGF by specifically activating a downstream pathway that leads to enhanced cell motility through an increase in Ca2+ influx, activation of extracellular-signal-regulated kinase 1/2 and remodelling of the actin cytoskeleton. These results, which identify extracellular HMGB1 as an activator of human tumour cell migration operating in concert with EGF, have important implications in the search for novel strategies to control tumour progression and metastatic invasion.
authors.affiliation: Department of Experimental Medicine, Biochemistry Section and Centre of Excellence for Biomedical Research, University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy. traspar@unige.it
authors.forename: Bianca
authors.initials: B
authors.lastname: Sparatore
authors.forename: Mauro
authors.initials: M
authors.lastname: Patrone
authors.forename: Mario
authors.initials: M
authors.lastname: Passalacqua
authors.forename: Marco
authors.initials: M
authors.lastname: Pedrazzi
authors.forename: Sabina
authors.initials: S
authors.lastname: Ledda
authors.forename: Sandro
authors.initials: S
authors.lastname: Pontremoli
authors.forename: Edon
authors.initials: E
authors.lastname: Melloni
mesh_terms: D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D024243:HMGB1 Protein / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D011485:Protein Binding
chemical_list: D024243:HMGB1 Protein; D004815:Epidermal Growth Factor; D002118:Calcium
references.citation: Biochem J. 1996 Nov 15;320 ( Pt 1):253-6
references.pmid: 8947495
references.citation: J Cell Sci. 1999 Apr;112 ( Pt 8):1149-58
references.pmid: 10085250
references.citation: Nature. 2000 May 18;405(6784):354-60
references.pmid: 10830965
references.citation: J Cell Biol. 2000 May 29;149(5):995-8
references.pmid: 10831602
references.citation: J Biol Chem. 2000 Dec 22;275(51):40096-105
references.pmid: 11007787
references.citation: J Exp Med. 2000 Aug 21;192(4):565-70
references.pmid: 10952726
references.citation: J Cell Biol. 2001 Mar 19;152(6):1197-206
references.pmid: 11257120
references.citation: EMBO J. 2001 Aug 15;20(16):4337-40
references.pmid: 11500360
references.citation: Exp Cell Res. 2002 Jan 1;272(1):84-91
references.pmid: 11740868
references.citation: J Biol Chem. 2002 Mar 1;277(9):7021-8
references.pmid: 11748221
references.citation: Biochem J. 2002 May 1;363(Pt 3):529-35
references.pmid: 11964153
references.citation: Gastroenterology. 2002 Sep;123(3):790-802
references.pmid: 12198705
references.citation: Blood. 2003 Apr 1;101(7):2652-60
references.pmid: 12456506
references.citation: J Cell Biochem. 2003 Aug 15;89(6):1126-37
references.pmid: 12898511
references.citation: FEBS Lett. 2003 Oct 9;553(1-2):11-7
references.pmid: 14550538
references.citation: J Cell Biol. 2004 Feb 2;164(3):441-9
references.pmid: 14744997
references.citation: J Intern Med. 2004 Mar;255(3):320-31
references.pmid: 14871456
references.citation: J Intern Med. 2004 Mar;255(3):332-43
references.pmid: 14871457
references.citation: J Intern Med. 2004 Mar;255(3):344-50
references.pmid: 14871458
references.citation: J Intern Med. 2004 Mar;255(3):351-66
references.pmid: 14871459
references.citation: J Biol Chem. 2004 Feb 27;279(9):7370-7
references.pmid: 14660645
references.citation: Free Radic Biol Med. 2004 Mar 1;36(5):555-64
references.pmid: 14980700
references.citation: J Biol Chem. 2004 Mar 26;279(13):12988-96
references.pmid: 14711810
references.citation: J Biol Chem. 2004 Mar 26;279(13):12967-73
references.pmid: 14726535
references.citation: Br J Pharmacol. 2004 Jun;142(4):635-46
references.pmid: 15172963
references.citation: Blood. 2004 Aug 15;104(4):1174-82
references.pmid: 15130941
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Biochemistry. 1981 Oct 13;20(21):6280-6
references.pmid: 6272837
references.citation: Cell. 1992 Apr 17;69(2):295-303
references.pmid: 1314702
references.citation: Exp Cell Res. 1992 Jun;200(2):444-51
references.pmid: 1369684
references.citation: J Biol Chem. 1993 Jan 25;268(3):1960-4
references.pmid: 8380583
references.citation: FEBS Lett. 1995 Jul 24;368(3):466-70
references.pmid: 7635200
references.citation: FEBS Lett. 1996 May 20;386(2-3):95-8
references.pmid: 8647297
references.citation: Neuroscience. 1998 Feb;82(4):1021-8
references.pmid: 9466426
references.citation: FEBS Lett. 1998 Jul 10;431(1):55-8
references.pmid: 9684864
references.citation: Biochem Biophys Res Commun. 1998 Sep 18;250(2):430-5
references.pmid: 9753647
references.citation: Biochem J. 1999 Jan 1;337 ( Pt 1):113-8
references.pmid: 9854032
references.citation: FEBS Lett. 1997 Jan 6;400(3):275-9
references.pmid: 9009213